Insights

Neurodegenerative Therapies Denali Therapeutics focuses on developing breakthrough therapies for neurodegenerative diseases, presenting an opportunity for partnerships with healthcare providers and institutions looking to advance treatments in this critical area of medicine.

Strategic Partnerships Recent collaborations with companies like Sanofi and Walmart showcase Denali's interest in strategic partnerships. Sales teams can explore further partnership opportunities with Denali to enhance their product offerings and market reach.

Technological Innovation Denali utilizes advanced technologies like brain engineering and biomarkers in their research. Tech companies providing complementary solutions or seeking to integrate innovative tech into biotechnology applications can explore potential partnerships with Denali.

Market Expansion With a recent financing of $500 million, Denali is poised for growth and market expansion. This presents a prime opportunity for sales professionals targeting biotech companies for investment, partnerships, or service offerings.

Employee Engagement Denali's collaborative and impact-focused work environment fosters employee satisfaction and productivity. HR solution providers or companies offering employee engagement services can target Denali as a potential client for enhancing staff well-being and performance.

Denali Therapeutics Tech Stack

Denali Therapeutics uses 8 technology products and services including MATLAB, Amazon S3, Squarespace, and more. Explore Denali Therapeutics's tech stack below.

  • MATLAB
    Advanced Analytics And Data Science
  • Amazon S3
    Content Delivery Network
  • Squarespace
    Content Management System
  • MySQL
    Database
  • Microsoft Excel
    Editors
  • ADP HRMS
    Human Resource Management System
  • Smartsheet
    Project Management
  • HSTS
    Security

Media & News

Denali Therapeutics's Email Address Formats

Denali Therapeutics uses at least 2 format(s):
Denali Therapeutics Email FormatsExamplePercentage
flast@dnli.comJDoe@dnli.com
62%
last@dnli.comDoe@dnli.com
32%
first.last@dnli.comJohn.Doe@dnli.com
6%
middle@dnli.comMichael@dnli.com
0%
flast@denalitherapeutics.comJDoe@denalitherapeutics.com
38%
first@denalitherapeutics.comJohn@denalitherapeutics.com
12%
flast@denalitherapeutics.comJDoe@denalitherapeutics.com
38%
first@denalitherapeutics.comJohn@denalitherapeutics.com
12%

Frequently Asked Questions

Where is Denali Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Denali Therapeutics's main headquarters is located at 161 Oyster Point Blvd South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Denali Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Denali Therapeutics is a publicly traded company; the company's stock symbol is DNLI.

What is Denali Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Denali Therapeutics's official website is denalitherapeutics.com and has social profiles on LinkedIn.

How much revenue does Denali Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2024, Denali Therapeutics's annual revenue reached $75M.

What is Denali Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Denali Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Denali Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, Denali Therapeutics has approximately 419 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief People Officer: C. D.Chief Scientific Officer, Head Of Discovery: J. L.Chief Operating And Financial Officer: A. S.. Explore Denali Therapeutics's employee directory with LeadIQ.

What industry does Denali Therapeutics belong to?

Minus sign iconPlus sign icon
Denali Therapeutics operates in the Biotechnology Research industry.

What technology does Denali Therapeutics use?

Minus sign iconPlus sign icon
Denali Therapeutics's tech stack includes MATLABAmazon S3SquarespaceMySQLMicrosoft ExcelADP HRMSSmartsheetHSTS.

What is Denali Therapeutics's email format?

Minus sign iconPlus sign icon
Denali Therapeutics's email format typically follows the pattern of . Find more Denali Therapeutics email formats with LeadIQ.

How much funding has Denali Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, Denali Therapeutics has raised $500M in funding. The last funding round occurred on Feb 27, 2024.

When was Denali Therapeutics founded?

Minus sign iconPlus sign icon
Denali Therapeutics was founded in 2015.
Denali Therapeutics

Denali Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.  Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development.

Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.

Section iconCompany Overview

Headquarters
161 Oyster Point Blvd South San Francisco, California 94080 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DNLI
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconFunding & Financials

  • $500M

    Denali Therapeutics has raised a total of $500M of funding over 6 rounds. Their latest funding round was raised on Feb 27, 2024.

  • $50M$100M

    Denali Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $500M

    Denali Therapeutics has raised a total of $500M of funding over 6 rounds. Their latest funding round was raised on Feb 27, 2024.

  • $50M$100M

    Denali Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.